AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human TrialM. Scott Harris, Barbara S. Fox, Hartman Deborah et al.|Journal of Crohn s and Colitis|2016Cited by 75
Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative ColitisDeborah Hartman, Barbara S. Fox, David M. Keane et al.|Journal of Crohn s and Colitis|2016Cited by 33